Sympathetic renal innervation and resistant hypertension

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Campese, Vito M ^a   Ku, Elaine ^a   Park, Jeanie ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANFACINE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA ANTIBODY; LOSARTAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BODY WEIGHT; BRAIN REGION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTINUOUS INFUSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; ESSENTIAL HYPERTENSION; HUMAN; HYPERACTIVITY; HYPOXIA; INTRACELLULAR SIGNALING; KIDNEY DENERVATION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY INNERVATION; NERVOUS SYSTEM FUNCTION; NEUROMODULATION; NONHUMAN; NORADRENALIN RELEASE; OXIDATIVE STRESS; PATHOGENESIS; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; RESISTANT HYPERTENSION; REVIEW; RISK ASSESSMENT; SODIUM RETENTION;

EID: 80054726461     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/814354     Document Type: Review

References (63)

1. Davis B. A., Crook J. E., Vestal R. E., Oates J. A., Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. New England Journal of Medicine 1979 301 23 1273 1276 2-s2.0-0018638977 (Pubitemid 10199256)
2. Svetkey L. P., Himmelstein S. I., Dunnick N. R., Wilkinson R. H., Bollinger R. R., McCann R. L., Beytas E. M., Klotman P. E., Prospective analysis of strategies for diagnosing renovascular hypertension. Hypertension 1989 14 3 247 257 2-s2.0-0024445287 (Pubitemid 19220000)
3. Izzo J. L., Campese V. M., Brenner B. M., Rector's F. C., Hypertension and renal disease. The Kindy 2004 7th New York, NY, USA Elsevier
4. Campese V. M., Malluche S. B., Hakim R. M., Sayegh M. H., Hypertension secondary to renal parenchymal disease. Clinical Nephroslogy, Dialysis, and Transplantation 1999 Dusti 7 12
5. Galla J. H., Brenner B. M., Hypertension in renal parenchymal disease. The Kidney 2000 Philadelphia, Pa, USA W. B. Saunders 2035 2058
6. Klag M. J., Whelton P. K., Randall B. L., Neaton J. D., Brancati F. L., Ford C. E., Shulman N. B., Stamler J., Blood pressure and end-stage renal disease in men. New England Journal of Medicine 1996 334 1 13 18 2-s2.0-0030034592 10.1056/NEJM199601043340103 (Pubitemid 26012498)
7. Foley R. N., Parfrey P. S., Harnett J. D., Kent G. M., Murray D. C., Barre P. E., Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney International 1996 49 5 1379 1385 2-s2.0-0030011060 (Pubitemid 26166411)
8. Johansson M., Elam M., Rundqvist B., Eisenhofer G., Herlitz H., Lambert G., Friberg P., Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999 99 19 2537 2542 2-s2.0-0033580596 (Pubitemid 29228284)
9. Lazarus J. M., Hampers C. L., Merrill J. P., Hypertension in chronic renal failure: treatment with hemodialysis and nephrectomy. Archives of Internal Medicine 1974 133 6 1059 1066 2-s2.0-0016236826 10.1001/archinte.133.6.1059
10. Schalekamp M. A.D.H., Schalekamp Kuyken M. P.A., De Moor Fruytier M., Interrelationships between blood pressure, renin, renin substrate and blood volume in terminal renal failure. Clinical Science and Molecular Medicine 1973 45 4 417 428
11. Brown J. J., Davies D. L., Morton J. J., Mechanism of renal hypertension. The Lancet 1976 1 1219 1221
12. Izzo J. L., Izzo M. S., Sterns R. H., Freeman R. B., Sympathetic nervous system hyperactivity in maintenance hemodialysis patients. TransactionsAmerican Society for Artificial Internal Organs 1982 28 604 607 (Pubitemid 13496500)
13. Cuche J. L., Prinseau J., Selz F., Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients. Kidney International 1986 30 4 566 572 2-s2.0-0022450853 (Pubitemid 16000802)
14. Ligtenberg G., Blankestijn P. J., Oey P. L., Klein I. H. H., Dijkhorst-Oei L. T., Boomsma F., Wieneke G. H., Van Huffelen A. C., Koomans H. A., Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. New England Journal of Medicine 1999 340 17 1321 1328 2-s2.0-0033614449 10.1056/NEJM199904293401704 (Pubitemid 29196594)
15. Converse R. L., Jacobsen T. N., Toto R. D., Jost C. M. T., Cosentino F., Fouad- Tarazi F., Victor R. G., Sympathetic overactivity in patients with chronic renal failure. New England Journal of Medicine 1992 327 27 I 1912 1918 2-s2.0-0027075024 (Pubitemid 23006966)
16. Ye S., Ozgur B., Campese V. M., Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney International 1997 51 3 722 727 2-s2.0-0030991661 (Pubitemid 27157956)
17. Bigazzi R., Kogosov E., Campese V. M., Altered norepinephrine turnover in the brain of rats with chronic renal failure. Journal of the American Society of Nephrology 1994 4 11 1901 1907 2-s2.0-0028431868
18. Calaresu F. R., Kim P., Nakamura H., Sato A., Electrophysiological characteristics of renorenal reflexes in the cat. Journal of Physiology 1978 283 141 154 2-s2.0-0018196428 (Pubitemid 9048102)
19. Ciriello J., Calaresu F. R., Central projections of afferent renal fibers in the rat: an anterograde transport study of horseradish peroxidase. Journal of the Autonomic Nervous System 1983 8 3 273 285 2-s2.0-0020523326 10.1016/0165-1838(83)90110-8 (Pubitemid 13043027)
20. DiBona G., The function of the renal nerves. Reviews of Physiology, Biochemistry & Pharmacology 1982 94 75 181
21. Faber J. E., Brody M. J., Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circulation Research 1985 57 5 676 688 2-s2.0-0022342839 (Pubitemid 16200677)
22. Brody M. J., Ganong W. F., Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation and hypertension. Frontiers in Neuroendocrinology 1980 New York, NY, USA Raven Press 249 292
23. Katholi R. E., Whitlow P. L., Hageman G. R., Woods W. T., Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. Journal of Hypertension 1984 2 4 349 359 2-s2.0-0021172352 (Pubitemid 14004193)
24. Wyss J. M., Aboukarsh N., Oparil S., Sensory denervation of the kidney attenuates renovascular hypertension in the rat. American Journal of Physiology 1986 250 1, part 2 H82 H86 2-s2.0-0022486570
25. Katholi R. E., Winternitz S. R., Oparil S., Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat. Journal of Clinical Investigation 1982 69 1 55 62 2-s2.0-0020041779 (Pubitemid 12212245)
26. Kopp U. C., Olson L. A., DiBona G. F., Renorenal reflex responses to mechano- and chemoreceptor stimulation in the dog and rat. The American journal of physiology 1984 246 1, part 2 F67 F77 2-s2.0-0021317482 (Pubitemid 14148474)
27. Katholi R. E., Renal nerves and hypertension: an update. Federation Proceedings 1985 44 13 2846 2850 2-s2.0-0022371504 (Pubitemid 16229758)
28. Campese V. M., Kogosov E., Koss M., Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. American Journal of Kidney Diseases 1995 26 5 861 865 2-s2.0-0028858468
29. Ye S., Gamburd M., Mozayeni P., Koss M., Campese V. M., A limited renal injury may cause a permanent form of neurogenic hypertension. American Journal of Hypertension 1998 11 723 728 2-s2.0-0031864055 10.1016/S0895-7061(98)00030-2 (Pubitemid 28313692)
30. Klein I. H. H. T., Ligtenberg G., Oey P. L., Koomans H. A., Blankestijn P. J., Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. Journal of the American Society of Nephrology 2001 12 11 2427 2433 2-s2.0-0034758803 (Pubitemid 33021120)
31. Campese V., Henrich W., Hypertension in dialysis patients. Principles and Practice of Dialysis 1999 Baltimore, Md, USA Williams & Wilkins 209 234
32. Campese V. M., Ye S., Zhong H., Downregulation of neuronal nitric oxide synthase and interleukin-1 β mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2002 39 2, part 2 519 524 2-s2.0-0036175204 10.1161/hy0202.102815 (Pubitemid 34165176)
33. Campese V. M., Ye S., Truong R. H., Gamburd M., Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure. Journal of the Renin-Angiotensin-Aldosterone System 2000 1 2 202 208 2-s2.0-0034211312
34. Ye S., Zhong H., Duong VU. N., Campese V. M., Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 2002 39 6 1101 1106 2-s2.0-0036278334 10.1161/01.HYP.0000018590.26853.C7 (Pubitemid 34620131)
35. Campese V. M., Ye S., Zhong H., Yanamadala V., Ye Z., Chiu J., Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. American Journal of Physiology 2004 287 2 H695 H703 2-s2.0-3242675168 10.1152/ajpheart.00619.2003 (Pubitemid 38955301)
36. Ye S., Zhong H., Campese V. M., Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 2006 48 2 309 315 2-s2.0-33748169328 10.1161/01.HYP.0000231307. 69761.2e (Pubitemid 44309828)
37. Kishi T., Hirooka Y., Kimura Y., Ito K., Shimokawa H., Takeshita A., Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004 109 19 2357 2362 2-s2.0-2442706556 10.1161/01.CIR. 0000128695.49900.12 (Pubitemid 38656873)
38. Oliveira-Sales E. B., Nishi E. E., Carillo B. A., Boim M. A., Dolnikoff M. S., Bergamaschi C. T., Campos R. R., Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. American Journal of Hypertension 2009 22 5 484 492 2-s2.0-67349247022 10.1038/ajh.2009.17
39. Campese V. M., Shaohua YE., Huiquin Z., Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005 46 3 533 539 2-s2.0-25444482850 10.1161/01.HYP.0000179088.57586.26 (Pubitemid 41376834)
40. Zimmerman M. C., Lazartigues E., Lang J. A., Sinnayah P., Ahmad I. M., Spitz D. R., Davisson R. L., Superoxide mediates the actions of angiotensin II in the central nervous system. Circulation Research 2002 91 11 1038 1045 2-s2.0-0037195696 10.1161/01.RES.0000043501.47934.FA (Pubitemid 35416641)
41. Nagae AI., Fujita M., Kawarazaki H., Matsui H., Ando K., Fujita T., Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 2009 119 7 978 986 2-s2.0-61849153939 10.1161/CIRCULATIONAHA.108.824730
42. Fujjita M., Ando K., Nagae A., Fujita T., Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007 50 2 354 359
43. Miyajima E., Yamada Y., Yoshida Y., Matsukawa T., Shionoiri H., Tochikubo O., Ishii M., Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991 17 6, part 2 1057 1062 2-s2.0-0026017880
44. Bernhardt W. M., Wiesener M. S., Weidemann A., Schmitt R., Weichert W., Lechler P., Campean V., Ong A. C. M., Willam C., Gretz N., Eckardt K. U., Involvement of hypoxia-inducible transcription factors in polycystic kidney disease. American Journal of Pathology 2007 170 3 830 842 2-s2.0-34247864018 10.2353/ajpath.2007.060455 (Pubitemid 47339353)
45. Bredt D. S., Hwang P. M., Snyder S. H., Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990 347 6295 768 770 2-s2.0-0025011298 10.1038/347768a0 (Pubitemid 20370722)
46. Vincent S. R., Kimura H., Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992 46 4 755 784 2-s2.0-0026531143 10.1016/0306-4522(92)90184-4
47. Tseng C. J., Liu H. Y., Lin H. C., Ger L. P., Tung C. S., Yen M. H., Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 1996 27 1 36 42 2-s2.0-0030066478
48. Barinaga M., Is nitric oxide the 'retrograde messenger'? Science 1991 254 5036 1296 1297 2-s2.0-0026321502
49. Togashi H., Sakuma I., Yoshioka M., Kobayashi T., Yasuda H., Kitabatake A., Saito H., Gross S. S., Levi R., A central nervous system action of nitric oxide in blood pressure regulation. Journal of Pharmacology and Experimental Therapeutics 1992 262 1 343 347 2-s2.0-0026717667
50. Harada S., Tokunaga S., Momohara M., Masaki H., Tagawa T., Imaizumi T., Takeshita A., Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circulation Research 1993 72 3 511 516 2-s2.0-0027460621 (Pubitemid 23052149)
51. Ye S., Nosrati S., Campese V. M., Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF). Journal of Clinical Investigation 1997 99 3 540 548 2-s2.0-0030752833 (Pubitemid 27414814)
52. Terao A., Oikawa M., Saito M., Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. American Journal of Physiology 1994 266 2, part 2 R400 R404 2-s2.0-0028133812
53. Liu S., Adcock I. M., Old R. W., Barnes P. J., Evans T. W., Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochemical and Biophysical Research Communications 1993 196 3 1208 1213 2-s2.0-0027431656 10.1006/bbrc.1993.2380 (Pubitemid 23347577)
54. Niijima A., Hori T., Aou S., Oomura Y., The effects of interleukin-1 β on the activity of adrenal, splenic and renal sympathetic nerves in the rat. Journal of the Autonomic Nervous System 1991 36 3 183 192 2-s2.0-0026038742 10.1016/0165-1838(91)90042-2
55. Shibata M., Parfenova H., Zuckerman S. L., Seyer J. M., Krueger J. M., Leffler C. W., Interleukin-1 peptides induce cerebral pial arteriolar dilation in anesthetized newborn pigs. American Journal of Physiology 1996 270 5 R1044 R1050 2-s2.0-0029973340
56. Ye S., Mozayeni P., Gamburd M., Zhong H., Campese V. M., Interleukin-1 β and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. American Journal of Physiology 2000 279 6 H2786 H2796 2-s2.0-0034530481 (Pubitemid 32005867)
57. Jin H., Yang R. H., Wyss J. M., Chen Y. F., Oparil S., Intrahypothalamic clonidine infusion prevents NaCl-sensitive hypertension. Hypertension 1991 18 2 224 229 2-s2.0-0025766691
58. Dorman T., Clarkson K., Rosenfeld B. A., Shanholtz C., Lipsett P. A., Breslow M. J., Effects of clonidine on prolonged postoperative sympathetic response. Critical Care Medicine 1997 25 7 1147 1152 2-s2.0-0030843745 10.1097/00003246-199707000-00015 (Pubitemid 27310254)
59. Campese V. M., Romoff M., Telfer N., Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension. Kidney International 1980 18 3 351 357 2-s2.0-0018976484 (Pubitemid 10015216)
60. Campes V. M., Levitan D., Romoff M. S., Saglikes Y., Sajo I., Massry S. G., Effect of sympa thetic nerve inhibition on the state of sodium volume balance in hypertensive pa-tients with normal or impaired renal function. Clinical Science 1982 63 301s 303s (Pubitemid 13210297)
61. Campese V. M., Massry S. G., Effects of acute and chronic treatment with clonidine. Chest 1983 83 2 380s 383s 2-s2.0-0020657162
62. Schlaich M. P., Sobotka P. A., Krum H., Lambert E., Esler M. D., Renal sympathetic-nerve ablation for uncontrolled hypertension. New England Journal of Medicine 2009 361 9 932 934 2-s2.0-69349085170 10.1056/NEJMc0904179
63. Krum H., Schlaich M., Whitbourn R., Sobotka P. A., Sadowski J., Bartus K., Kapelak B., Walton A., Sievert H., Thambar S., Abraham W. T., Esler M., Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. The Lancet 2009 373 9671 1275 1281 2-s2.0-64049084640 10.1016/S0140-6736(09)60566-3